Phyu Sin Aye
Clinical Oncology Society of Australia Annual Scientific Meeting 2023
Days
Wednesday, 1st November
Thursday, 2nd November
Friday, 3rd November
Search
Speakers
Phyu Sin Aye
Abstracts this author is presenting:
National retrospective cohort study of safety and effectiveness of erlotinib and gefitinib in New Zealand for treating EGFR mutated lung cancer: Study protocol and results of the validation sub-study
—
Lunch, Poster Viewing, Exhibition & COSA Group Meetings